RVINE, Calif.--(BUSINESS WIRE)--PrimeCell™ Therapeutics LLC (http://www.primecelltherapeutics.com) today announced that it provided research support and pre-clinical studies for a clinical trial that involved the implantation of autologous adult bone marrow stem cells into spinal cord injury (SCI) patients – resulting in some restored function for patients who have been paralyzed for an average of four years, some up to 22 years.
